Physician profile
Warren Albrecht
NPI 1134146129
$2,594.11
in general payments reported to CMS, 2019-2025
13 companies · $179 in 2025
The $179 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.55 · 2022: $1,722 · 2023: $430 · 2024: $200 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $809.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $1,736.91 | 2022-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Penumbra, INC. | $216.39 | 2023-2024 | Indigo System, Penumbra System |
| Kerecis Limited | $152.19 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Medtronic, INC. | $119.20 | 2022-2024 | Endurant Iis |
| Cvrx, INC. | $67.67 | 2023 | Barostim Neo System |
| Shockwave Medical, INC | $64.05 | 2025 | |
| Medtronic Vascular, INC. | $62.55 | 2019 | |
| Stryker Corporation | $61.37 | 2025 | Flowtriever, Clottriever Bold Catheter |
| Lemaitre Vascular, INC. | $35.34 | 2024 | Pruitt F3 Carotid Shunt |
| Organogenesis INC. | $23.31 | 2025 | Puraply Wound Matrix |
| Janssen Pharmaceuticals, INC | $20.89 | 2023 | Xarelto |
| Urgo Medical North America, LLC | $20.54 | 2023 | Urgok2 |
| E.R. Squibb & Sons, L.L.C. | $13.70 | 2024 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Warren Albrecht listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.